Skip to main content

Case details

Case Number: App_460220/2023

  • Patent number:
    EP4034121 - TREATMENT OF EGFR MUTANT-RELATED CANCERS USING A COMBINATION OF EGFR AND CDK4/6 INHIBITORS

  • Proceeding type: Application

  • Action/Application: Opt-out

  • Applicants:
    Novagraaf Technologies Represented by Marie-Noelle de la Fouchardiere

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-01 09:32:34